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Intestinal helminth co‑infection 
is an unrecognised risk factor 
for increased pneumococcal 
carriage density and invasive 
disease
Alice E. Law1,5, Rebecca K. Shears1,5, Andrea A. Lopez Rodas2, Richard K. Grencis3, 
Philip J. Cooper2,4, Daniel R. Neill1,6 & Aras Kadioglu1,6* 
Infection with Streptococcus pneumoniae is the leading cause of death in children and burden of 
disease is greatest where helminth infections are also common. We investigated the impact of 
intestinal helminth co‑infection on pneumococcal carriage; a risk factor for invasive disease. We 
used a mouse co‑infection model and clinical data to assess the impact of co‑infection on carriage 
density. Co‑infection in mice was associated with increased pneumococcal carriage density and 
dissemination into lungs. Helminth‑infected children also exhibited increased carriage density as 
compared to uninfected children. Anthelmintic treatment may be a cost‑effective method of reducing 
pneumococcal disease burden in lower‑income countries.
Multi-species co-infections pose one of the greatest challenges to world health, particularly in lower-income 
countries where major global pathogens such as HIV, malaria and soil-transmitted helminth (STH) infection 
are co-endemic1. A pathogen’s disease potential can be magnified by their relationship with other pathogens and 
co-infections involving intestinal helminths are of particular interest due to their ability to modulate systemic 
host  immunity2–4. This modulation ensures chronicity of infection from childhood through to adult life and 
influences immune homeostasis and inflammatory responses to microbial  pathogens3,4.
Streptococcus pneumoniae is the leading bacterial cause of child mortality, accounting for 341,000 deaths in 
children under-5 per  annum5. The spectrum of pneumococcal diseases ranges from localised infections, such 
as sinusitis or otitis media, through to pneumonia, sepsis and  meningitis6. Colonisation of the human naso-
pharynx by the pneumococcus is known to be a prerequisite for invasive  disease7. Where carriage rates are high, 
pneumococcal pneumonia, and other forms of invasive pneumococcal disease, are a significant burden to public 
health  services7 and this is most apparent within resource-constrained regions of the  world6. STH infections are 
prevalent amongst these same populations, with an estimated 1.45 billion individuals infected  worldwide8. The 
main species of STHs of clinical relevance are Trichuris trichiura, Ascaris lumbricoides and  hookworms8. Most 
infants acquire pneumococcal carriage early in life, with numerous independent colonisation events occurring 
throughout  childhood7. Early childhood is a time of exposure to multiple pathogens, including  STHs8, and so 
co-infection is likely a common occurrence. However, detailed studies to define the incidence of pneumococcal-
STH co-infection in human populations have yet to be performed.
OPEN
1Department of Clinical Immunology, Microbiology and Immunology, Institute of Infection, Veterinary and 
Ecological Sciences, University of Liverpool, Liverpool, UK. 2School of Medicine, Universidad Internacional del 
Ecuador, Quito, Ecuador. 3School of Biological Sciences, Lydia Becker Institute of Immunology and Inflammation, 
Wellcome Centre for Cell Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health 
Science Centre, University of Manchester, Manchester, UK. 4Institute of Infection and Immunity, St George’s 
University of London, London, UK. 5These authors contributed equally: Alice E. Law and Rebecca K. Shears. 6These 
authors jointly supervised this work: Daniel R. Neill and Aras Kadioglu. *email: a.kadioglu@liverpool.ac.uk
2
Vol:.(1234567890)
Scientific Reports |         (2021) 11:6984  | https://doi.org/10.1038/s41598-021-86508-4
www.nature.com/scientificreports/
Results
Intestinal helminth co‑infection increases pneumococcal carriage density and leads to signifi‑
cantly enhanced dissemination into lungs. We established a T. muris (mouse whipworm) and S. pneu-
moniae co-infection model to determine whether STH infection altered pneumococcal carriage density, and/
or dissemination into the lower airways. Mice were infected with T. muris, and 28 days later, when the worms 
had matured into adults, mice were infected with a carriage-inducing dose of S. pneumoniae. Co-infection with 
T. muris led to a consistent increase in nasopharyngeal carriage density over time, which may be biologically 
important, although this did not reach statistical significance (P = 0.062, Fig. 1A). In the lungs, a substantial dif-
ference was observed whereby co-infected mice had significantly increased pneumococcal dissemination into 
their lungs at 1, 3, and 7 days post-infection (Fig. 1B). Co-infection led to a significant increase in the number 
of macrophages within the nasopharynx compared to mono-infected animals (P = 0.0118, Fig. 1C) and a clear 
trend towards increased neutrophils (P = 0.0561, Fig.  1D), which was reversed by anti-helminthic treatment 
(P = 0.0083 and 0.0019 for macrophages and neutrophils respectively). Anthelminthic treatment also led to a 
small (but non-significant, P = 0.075) reduction in nasopharyngeal bacterial load (Fig. S1).
Intestinal helminth co‑infection is a risk factor for increased pneumococcal carriage density in 
Ecuadorian children. We next investigated whether STH co-infection was also associated with increased 
pneumococcal carriage density in children. A total of 387 children enrolled in the ECUAVIDA study (age range 
54–95  months, median = 60  months) were tested for pneumococcal carriage as measured by lytA PCR per-
Figure 1.  Effects of intestinal helminth co-infection and anthelmintic treatment on pneumococcal infection 
dynamics and host immune responses. Mice were infected with 20 T. muris eggs by oral gavage, followed 
by induction of pneumococcal carriage 28 days later. Co-infected mice had a trend towards increased 
nasopharyngeal carriage density as compared to pneumococcus only infected animals (A) and this was 
accompanied by significantly increased pneumococcal dissemination into lungs of co-infected animals (B). 
Co-infection was accompanied by increased macrophages (C) and neutrophils (D), which was reversed by 
anthelminthic treatment. S.p. = S. pneumoniae, T.m. = T. muris, MBZ = mebendazole, 6 h = 6 hours, 1d = 1 day. 
Mean and SEM are indicated, *(P < 0.05) and **(P < 0.01). Broken line indicates limit of detection (50 colonies).
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formed on oropharyngeal swabs, collected as  described9. Pneumococcal carriage density (as measured by num-
ber of lytA copies) was higher in STH-infected children than uninfected children (Fig. 2), although this did not 
reach significance. A. lumbricoides infections were associated with the largest increase in pneumococcal density 
(P = 0.029, univariable analysis) of all the factors measured (Table 1). Multivariable analysis was performed with 
all helminth infections and age, sex and household overcrowding were included a  priori10. PCV13 vaccination 
status was not included in the analyses, as only 1.8% of children sampled had received the vaccine.
Discussion
The impact of a single pathogen is likely multiplied in the context of one or more co-infections in complex and 
challenging ways, particularly for STHs, which have evolved to modulate the host immune response, in order 
to favour chronicity of  infection4. The impact of STH co-infection on pneumococcal disease burden and out-
come is largely unknown despite sharing prevalence in the same geographical regions of the world. Therefore, 
we sought to study this using a combination of mouse models and human data. Here, we demonstrate that the 
murine intestinal helminth, T. muris, enhances pneumococcal (D39) nasopharyngeal carriage density and sig-
nificantly increases pneumococcal CFU load in the lungs. Although D39 is virulent in mice, it does not cause 
invasive pneumonia when used in models of carriage, in the absence of other stimuli, instead providing a stable 
and reproducible model of long-term asymptomatic nasopharyngeal infection. It thus offers an opportunity to 
investigate bacterial, host and environmental factors which control carriage or that perturb stable nasopharyn-
geal infection towards invasive  disease11–13. We show that co-infection with T. muris drives host immune cell 
infiltration with increased macrophages and neutrophils in the nasopharynx of co-infected mice; suggesting a 
pro-inflammatory environment conducive to increased pneumococcal lung dissemination, as has been shown 
 previously14. Interestingly, increases in pneumococcal carriage density and cellular infiltration were both reduced 
by anthelmintic treatment. Similar mechanisms may also be at play in humans, as we observed increased pneu-
mococcal carriage density in helminth-infected Ecuadorian children, as compared to uninfected children, and 
previous studies have shown a link between increased carriage density and pneumococcal pneumonia in both 
mice and  humans11,14–17. As the lytA qPCR is not as specific for oropharyngeal swabs as it is for nasopharyngeal 
swabs, we sought to confirm pneumococci with a second PCR for cpsA; there was a positive correlation between 
pneumococcal DNA copies of both genes as determined by cpsA and lytA qPCR (P < 0.0001). The largest dif-
ference in pneumococcal density was recorded in A. lumbricoides infected children, however, it is not possible 
to study chronic A. lumbricoides infection in mice since the parasite is expelled before the adult worms establish 
in the gastrointestinal  tract18, which is why we opted for another roundworm species, T. muris, a close relative 
of T. trichuira19. Our study had a relatively small sample size (68 lytA positive children out of 387 in total), and 
therefore it is possible that interactions may have been missed where effect sizes were small, for instance in the 
case of T. trichuira co-infection. Similarly, some of the observations reported using our mouse model fall short 
of reaching statistical significance (for example, the increase in nasopharyngeal neutrophil count for co-infected 
versus those infected with pneumococci only). Future studies should seek to further validate these observations 
as well as providing additional mechanistic understanding of these processes.
Figure 2.  Pneumococcal carriage density in STH-uninfected versus STH-infected children. lytA PCR 
was performed on oropharyngeal swabs collected as part of the ECUAVIDA cohort study in order to 
determine pneumococcal carriage density in STH-uninfected (STH-) and STH-infected (STH +) respectively. 
STH + includes T. trichiura, A. lumbricoides and mixed T. trichiura/A. lumbricoides infections combined. Red 
outline indicates A. lumbricoides infections alone. Median and IQR are indicated.
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Overall, these data suggest that coordinated deworming programmes alongside pneumococcal vaccination 
may aid in the reduction of pneumococcal disease in areas of the world where STH infections are also common. 
Pneumococcal carriage is known to be a risk factor for pneumococcal pneumonia, and non-vaccine therapeutic 
methods to reduce carriage density could also have a major impact on the prevalence of pneumococcal pneu-
monia at low economic  cost7.
In summary, our data suggest that intestinal helminth co-infection is associated with increased levels of 
pneumococcal carriage and a clear and significant increase in bacterial dissemination to the lower airways. Given 
that the incidence of pneumococcal disease is highest in areas of the world where STH infections are most com-
mon, these data suggest that anthelminthic treatment could be a cost-effective method to reduce pneumococcal 
disease in lower-income countries.
Methods
All experimental protocols were approved by either the University of Liverpool Ethical and Animal Welfare 
Committee or by the ethics committees of the Hospital Pedro Vicente Maldonado and the Universidad San 
Francisco de Quito.
Mice. All experimental protocols were performed in accordance with the Home Office Scientific Procedures 
Act (1986), Project Licence P86De83DA, and the University of Liverpool Ethical and Animal Welfare Com-
mittee, which approved the study. All procedures were carried out in compliance with ARRIVE guidelines. All 
procedures were carried out on MF1 mice 6–8 weeks or older. Mice were acclimatised for one-week prior to use 
and had free access to food and water in individually-ventilated cages.
Bacteria. S. pneumoniae Serotype 2 strain D39 (NCTC 7466) was used for all in vivo experiments. Bacteria 
were cultured as described  previously11.
Table 1.  Linear regression analysis of factors associated with S. pneumoniae density in children aged 
54–95 months who are carriers. Analysis was restricted to positive carriers (no. of carriers/total for each 
category is indicated in summary statistic column) and results are reported as linear regression coefficients 
and 95% CI. All helminth infections alongside age and sex were then used in a multivariable regression model 
to estimate adjusted coefficients and identify independent associations. aCoeficient was log10 converted, e.g. 
those with A. lumbricoides infection have a pneumococcal density of 0.3 log10 higher than those with no active 
infection. bThe first component that accounted for 30% of variation was divided into tertiles to represent low, 
middle and high socioeconomic status as described by Menzies et al. (2014)22. Median age for participants was 




Log10 LytA DNA 
copies/mL
Univariable analysis Multivariable analysis
Crude  coefficienta 
(95% CI) P value
Adjusted  coefficienta 
(95% CI) P value
Age (n = 387) 68/387 (17.5) 1.9 − 0.412 (− 0.06, 0.04) 0.682 − 0.024 (− 0.06, 0.05) 0.847
Sex (n = 391) 0.18 0.367
Male 38/204 (18.6) 1.79 1
Female 30/187 (16.0) 2.03 0.170 (− 0.11, 0.58) 0.118 (− 0.19, 0.51)
Socioeconomic status (n = 231)b
Medium 13/100 (13.0) 2.06 1
High 26/131 (19.7) 1.98 − 0.06 (− 0.38, 0.55) 0.722
Household (n = 391)
Urban 47/259 (18.1) 1.95 1
Rural 21/132 (15.9) 1.76 − 0.127 (− 0.56, 0.19) 0.319
Household overcrowding (n = 391) 0.077
No 30/189 (15.9) 2.05 1
Yes 38/202 (18.8) 1.77 − 0.206 (− 0.62, 0.06) 0.103 − 0.236 (− 0.69, 0.36)
Respiratory symptoms (wheeze) (n = 391)
No 59/242 (24.4) 1.93 1
Yes 9/49 (18.4) 1.71 − 0.108 (− 0.71, 0.28) 0.394
Type of helminth infection (n = 391)
No active infection 25/115 (21.7) 1.69 1 1
T. Trichuira 14/100 (14.0) 1.94 0.156 (− 0.20, 0.71) 0.265 0.142 (− 0.25, 0.72) 0.339
A. Lumbricoides 11/88 (12.5) 2.26 0.304 (0.59, 1.08) 0.029 0.275 (− 0.003, 1.04) 0.051
Mixed 18/88 (20.5) 1.93 0.158 (− 0.19, 0.68) 0.263 0.214 (− 0.13, 0.81) 0.154
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Parasites. The Edinburgh (E) strain of T. muris was used for all experiments. Parasite maintenance was car-
ried out at the University of Manchester, as described  previously20.
Mouse model of pneumococcal/helminth co‑infection. Mice were infected by oral gavage with 20 T. 
muris embryonated eggs in 200µL  ddH2O. Control mice were sham infected with 200µL  ddH2O. Twenty-eight 
days later, mice were lightly anaesthetised with a mixture of  O2 and isofluorane and infected intranasally with 
1 ×  105 colony-forming units (CFU) S. pneumoniae D39 in 10µL PBS, as previously  described11. In those animals 
treated with the anthelmintic, mebendazole, the drug was administered by oral gavage once daily (100 mg/kg) 
for three days, immediately after S. pneumoniae infection. Control mice (S.p. only and S.p. + T.m. groups) were 
sham treated with 200µL PBS by oral gavage. At pre-selected time intervals following intranasal infection, mice 
were humanely culled, nasopharynx and lungs were removed and blood was collected via cardiac puncture. A 
viable count of bacteria was determined at each interval by serial dilution of tissue homogenates onto blood 
agar, as previously  described11. Worm burden was measured as described  previously20. Single cell suspension 
from the nasopharynx were stained as follows: CD45-FITC, GR1-PE-CY7 (RB6-8C5, BD Biosciences), CD11b-
PE (M1/70, Biolegend) and F4/80-Pacific blue (T45-2342, BD Biosciences). Acquisition was carried out using 
a FACSCanto flow cytometer (BD Biosciences) and analysis performed using Flowjo X (Treestar). Fluorescent 
minus one controls for each of the included antibodies were used to validate results.
Assessment of rate and density of S. pneumoniae carriage in Ecuadorian children. Total DNA 
was extracted from oropharyngeal swabs collected as part of the ECUAVIDA cohort  study9 using an Agowa 
Mag mini DNA extraction kit (LGC Genomics). The ECUAVIDA cohort consists of 2404 newborns recruited 
between 2006 and 2009 to study the impact of soil-transmitted helminths (STHs) and early-life microbial expo-
sures on the development of atopy, allergic diseases and immune responses in childhood. Informed written 
consent was obtained from the mothers of participating children and all methods were carried out in accordance 
with local guidelines and  regulations9. The ECUAVIDA study was approved by the Ministry of Health in Ecua-
dor and by the ethics committees of the Hospital Pedro Vicente Maldonado and the Universidad San Francisco 
de Quito. The study is registered as an observational study (ISRCTN 41,239,086). Carriage density by qPCR 
was determined by partial amplification of the lytA gene of S. pneumoniae, as described  previously21. Carriage 
density was also assessed using the cspA gene and there was a positive correlation between pneumococcal DNA 
copies of both genes as determined by cpsA and lytA qPCR (P < 0.0001, Fig. S2). Samples were only classified as 
positive for pneumococci if both lytA and cpsA qPCR signals were > 10 DNA copies (< 40 cycles). 49 swabs were 
determined to be negative for pneumococci based upon dissimilarity between the lytA and cpsA qPCR results. 
Overall, 68 swabs were determined as pneumococci positive. Anthelmintic treatment was administered to chil-
dren who tested positive for helminth infection for ethical reasons.
Statistical analysis. For the murine experiments, statistical analysis was carried out using GraphPad Prism 
7. Mann–Whitney U test and ANOVA with Kruskall-Wallis post-test were performed when comparing two and 
three or more experimental groups, respectively. Error bars represent SEM. Statistical significance is denoted by 
*(P < 0.05) and **(P < 0.01).
For clinical data, statistical analysis was performed using IBM SPSS version 25. Bacterial density data were 
 log10 transformed and linear regression was used to assess relationships between potential risk factors and 
colonisation density. Analysis was restricted to positive carriers and results were reported as linear regression 
coefficients and 95% confidence interval (CI). Covariates significant at P < 0.1 alongside age, sex and household 
crowding (selected a priori)10 were then used in a multivariable regression model to estimate adjusted coefficients 
and identify independent associations.
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